The yellow fever specific peptide epitope K9F (KTWGKNLVF) and two synthetic variants, K9A (KTWGKNLVA) and K9V (KTWGKNLVV), were synthesized by standard 9-fluorenylmethyloxycarbonyl (FMOC) chemistry and purified by reversed-phase high-performance liquid chromatography (purity at least 80%, usually >95%) (Schafer-N, Copenhagen, Denmark). Tetramers were produced as previously described [21 (link)] with the following modification: abacavir (ABC; 200 μg/ml) was added to the folding reaction for the production of the variant tetramers, K9A-ABC-B*57:01 and K9V-ABC-B*57:01. Successfully folding of MHC-I monomers with these peptides was strictly abacavir dependent. To tetramerize the complexes Streptavidin-R-Phycoerythin (PE), Streptavidin-Allophycocyanin (APC), or Streptavidin-Brilliant Violet 421 (BV421) (Biolegend, San Diego, USA) was sequentially added over 60 min at a molar ratio of Streptavidin to peptide-MHC-I monomer of 1:4.
Free full text: Click here